Efficacy of Human-Simulated Epithelial Lining Fluid Exposure of Meropenem-Nacubactam Combination against Class A Serine β-Lactamase-Producing Enterobacteriaceae in the Neutropenic Murine Lung Infection Model

Ítems similars

• 1368. Assessment of the In Vivo Efficacy of Human-Simulated Epithelial Lining Fluid (ELF) Exposure of Meropenem/Nacubactam (MEM/NAC) Combination Against β-Lactamase-Producing Enterobacteriaceae in Neutropenic Lung Infection Model
  per: Asempa, Tomefa E, et al.
  Publicat: (2018)
• In Vivo Efficacy of Meropenem with a Novel Non-β-Lactam–β-Lactamase Inhibitor, Nacubactam, against Gram-Negative Organisms Exhibiting Various Resistance Mechanisms in a Murine Complicated Urinary Tract Infection Model
  per: Monogue, Marguerite L., et al.
  Publicat: (2018)
• Synergistic Activity of Exebacase (CF-301) in Addition to Daptomycin against Staphylococcus aureus in a Neutropenic Murine Thigh Infection Model
  per: Asempa, Tomefa E., et al.
  Publicat: (2020)
• The Ongoing Challenge with NDM-Harboring Enterobacteriaceae in Murine Infection Models
  per: Asempa, Tomefa E., et al.
  Publicat: (2021)
• 1296. Efficacy of Human-Simulated Exposures of Meropenem/Vaborbactam (MVB) and Meropenem (MEM) against OXA-48 β-lactamase-producing Enterobacterales in the Neutropenic Murine Thigh Infection Model
  per: Gill, Christian M, et al.
  Publicat: (2020)